• Home
  • Transactions

Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering

tonix pharmaceuticals

NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) –New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage pharmaceutical company focused on researching common disorders of the central nervous system, on a recently completed $7.8 million registered direct public offering pursuant to Tonix’s shelf registration statement. The offering consisted of 657,000 shares of common stock sold at $11.90 per share. Roth Capital Partners acted as the sole placement agent in this offering. The Sichenzia Ross Friedman Ference LLP team consisted of partners Marc J. Ross and James M. Turner and associate Sharon Carroll.

Media Contact
pr@srf.law
(212)-930-9700

Sichenzia Ross Ference LLP
Click Here to Leave a Comment Below 0 comments

Leave a Reply: